TTPA has a versioned database record, but no eligible observed perturbation in the current HepG2 release.
Gene evidence summary
TTPA
Current recommendation: Design an experiment that closes the main evidence gap.
Different DMD datasets do not fully agree on the disease-associated direction. A matched perturbation in a DMD-relevant muscle model is the truth needed to calibrate a future DMD-response model.
Design an experiment that closes the main evidence gap. Use independent reagents and biological replication, and predeclare one functional endpoint.
Current value: this record identifies the most informative next experiment and the result needed for model calibration. It does not yet establish a therapeutic or clinical conclusion.
Evidence journey
Where TTPA stands—and what creates the next evidence
Read left to right from released knowledge to translation. The highlighted next step is a research decision, not a target score.
01 · Database supportVersioned gene recordStable identity, provenance and downloadable evidence are available.
→02 · Disease contextDMD context assembledSource-specific DMD signals are retained separately for interpretation.
→03 · Model evidenceCalibration truth neededThe current evidence defines what a future DMD-response model must learn and test.
→04 · Experimental perturbationPerturbation study neededA controlled perturbation can establish the first response truth.
→05 · Functional phenotypeNext decision experimentDesign an experiment that closes the main evidence gap
→06 · Clinical evidenceFuture translation layerClinical interpretation follows reproducible disease-matched functional evidence.
Data behind this summary
Exact values currently available for TTPA
These values come from different biological contexts and are displayed separately. They are not combined into one target score.